case 3: therapeutic approaches for richter transformation
Published 6 years ago • 165 plays • Length 5:03Download video MP4
Download video MP3
Similar videos
-
7:03
case 3: progression on ibrutinib followed by richter transformation
-
5:47
case 3: response to frontline therapy and toxicity management
-
1:18
an overview of a study combining nivolumab with ibrutinib in cll and richter transformation
-
26:51
richter’s syndrome: risk, predictors, and treatment
-
4:10
case 3: intolerance to btk inhibitors in cll
-
8:19
case 3: an elderly patient with cll, mutated tp53 and notch, unmutated ighv
-
0:59
dr. jain discusses treatment of richter's transformation in cll
-
4:47
case 3: risk assessment and elderly patients with cll
-
27:37
therapeutic options for richter’s syndrome
-
23:28
richter’s syndrome: what are the options?
-
19:37
richter’s: who will get, what to do?
-
1:12
novel treatment strategies for richter’s transformation
-
7:05
case 4: treatment of relapsed cll
-
9:14
the use of ngs in the diagnosis and treatment of richter’s transformation
-
1:27
are there cll clinical trials studying richter’s transformation?
-
3:45
therapeutic approach for cll relapse
-
0:43
the role of richter’s syndrome in determining the prognosis of cll patients
-
10:14
cll: the risk of richter’s transformation
-
1:08
richter’s transformation: the need for more therapeutic agents in this space